MX2015006757A - Método para la evaluación de la presencia de o riesgo de tumores de colon. - Google Patents

Método para la evaluación de la presencia de o riesgo de tumores de colon.

Info

Publication number
MX2015006757A
MX2015006757A MX2015006757A MX2015006757A MX2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A
Authority
MX
Mexico
Prior art keywords
colum
tumors
evaluating
risk
patient
Prior art date
Application number
MX2015006757A
Other languages
English (en)
Spanish (es)
Inventor
John Blume
Ryan Benz
Lisa Croner
Roslyn Dillon
Arlo Randall
Jeffrey Jones
Heather Skor
Tom Stockfisch
Bruce Wilcox
Daniel Ruderman
Original Assignee
Applied Proteomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Proteomics Inc filed Critical Applied Proteomics Inc
Publication of MX2015006757A publication Critical patent/MX2015006757A/es

Links

Classifications

    • G01N33/57535—
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Data Mining & Analysis (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
MX2015006757A 2012-11-30 2013-12-02 Método para la evaluación de la presencia de o riesgo de tumores de colon. MX2015006757A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261732024P 2012-11-30 2012-11-30
US201361772979P 2013-03-05 2013-03-05
PCT/US2013/072691 WO2014085826A2 (en) 2012-11-30 2013-12-02 Method for evaluation of presence of or risk of colon tumors

Publications (1)

Publication Number Publication Date
MX2015006757A true MX2015006757A (es) 2015-11-30

Family

ID=50828610

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006757A MX2015006757A (es) 2012-11-30 2013-12-02 Método para la evaluación de la presencia de o riesgo de tumores de colon.

Country Status (11)

Country Link
US (6) US20140234854A1 (enExample)
EP (1) EP2926138A4 (enExample)
JP (1) JP2016507723A (enExample)
KR (1) KR20150090240A (enExample)
CN (2) CN110596385A (enExample)
AU (1) AU2013351947A1 (enExample)
BR (1) BR112015012616A2 (enExample)
CA (1) CA2893158A1 (enExample)
MX (1) MX2015006757A (enExample)
SG (1) SG11201504241QA (enExample)
WO (1) WO2014085826A2 (enExample)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
AU2013217935B2 (en) 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
JP2017520775A (ja) * 2014-03-28 2017-07-27 アプライド プロテオミクス，インク． 結腸直腸腫瘍を検出するためのタンパク質バイオマーカープロファイル
EP3167293B1 (en) * 2014-07-11 2020-03-18 Expression Pathology, Inc. Srm/mrm assay for the gtpase kras protein (kras)
CA3190715A1 (en) 2014-08-14 2016-02-18 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
WO2016037134A1 (en) * 2014-09-05 2016-03-10 Nantomics, Llc Systems and methods for determination of provenance
CA2968650A1 (en) 2014-12-11 2016-06-16 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
KR102457151B1 (ko) * 2014-12-11 2022-10-19 위스콘신 얼럼나이 리서어치 화운데이션 대장암의 검출 및 치료를 위한 방법
CN105807062A (zh) * 2014-12-28 2016-07-27 复旦大学 人结肠癌蛋白Spondin-2在制备结肠癌诊断制剂中的应用
CN105385752A (zh) * 2015-03-23 2016-03-09 复旦大学 一种人结肠癌蛋白质标志物Spondin-2的检测方法及其检测试剂盒
CA2982169A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
WO2017004390A1 (en) * 2015-07-01 2017-01-05 Duke University Methods to diagnose and treat acute respiratory infections
JP6742034B2 (ja) * 2015-11-05 2020-08-19 ヴァンダービルト ユニバーシティー 多細胞組織検体におけるタンパク質の定量
CN108699583B (zh) 2016-03-03 2022-11-01 米密德诊断学有限公司 用于区分细菌和病毒感染的rna决定子
WO2017180652A1 (en) * 2016-04-11 2017-10-19 Applied Proteomics, Inc. Mass spectrometric data analysis workflow
JP6754116B2 (ja) * 2016-04-26 2020-09-09 学校法人近畿大学 大腸癌マーカー
CN107345236A (zh) * 2016-05-04 2017-11-14 北京美泽福临科技发展有限公司 一种amy2b信使rna的特异性扩增引物和肝癌辅助诊断试剂盒
EP3469369A1 (en) * 2016-06-10 2019-04-17 Wisconsin Alumni Research Foundation Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas
EP3482200B1 (en) 2016-07-10 2022-05-04 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
CN106202984B (zh) * 2016-08-26 2018-09-04 赵毅 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法
US11385241B2 (en) 2016-09-29 2022-07-12 Memed Diagnostics Ltd. Methods of prognosis and treatment
CN110073220A (zh) * 2016-09-29 2019-07-30 米密德诊断学有限公司 风险评估和疾病分类的方法
US20180100858A1 (en) * 2016-10-07 2018-04-12 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US11423331B2 (en) 2017-01-19 2022-08-23 Shimadzu Corporation Analytical data analysis method and analytical data analyzer
US11204355B2 (en) 2017-02-20 2021-12-21 Vanderbilt University Immune checkpoint molecular fitness profiling by mass spectrometry
CN106919801B (zh) * 2017-03-08 2023-07-18 杭州大伽信息科技有限公司 一种免疫组织化学染色辅助分析系统及使用方法
CN106908608B (zh) * 2017-04-17 2018-10-02 首都医科大学附属北京胸科医院 辅助诊断重症继发性肺结核的蛋白标志物
US20180330059A1 (en) 2017-05-09 2018-11-15 James Stewart Bates Patient treatment systems and methods
US10455457B2 (en) 2017-05-24 2019-10-22 Qualcomm Incorporated NR-SS unified operation mode in coordinated and uncoordinated bands
US11164679B2 (en) 2017-06-20 2021-11-02 Advinow, Inc. Systems and methods for intelligent patient interface exam station
CA3068688A1 (en) * 2017-06-30 2019-01-03 National Institutes Of Biomedical Innovation, Health And Nutrition Biomarker for detecting colorectal cancer
CA3069828A1 (en) * 2017-07-14 2019-01-17 Cofactor Genomics, Inc. Immuno-oncology applications using next generation sequencing
CN109406785A (zh) * 2017-08-18 2019-03-01 山东泽济生物科技有限公司 肿瘤血液标志物及其应用
US20200386759A1 (en) * 2017-12-05 2020-12-10 Discerndx, Inc. Robust panels of colorectal cancer biomarkers
CN111699391A (zh) * 2017-12-29 2020-09-22 雅培实验室 用于诊断和评估创伤性脑损伤的新型生物标志物和方法
CA3088754A1 (en) 2018-01-22 2019-07-25 Liquid Biopsy Research LLC Methods for colon cancer detection and treatment monitoring
US11348688B2 (en) 2018-03-06 2022-05-31 Advinow, Inc. Systems and methods for audio medical instrument patient measurements
CA3095056A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
KR102745118B1 (ko) * 2018-07-05 2024-12-23 이디피 바이오테크 코퍼레이션 마커 검출용 키트 및 방법
EP3833775B1 (en) 2018-08-08 2025-06-25 Regeneron Pharmaceuticals, Inc. Use of lc-ms/ms to quantitate protein biomarkers
EP3623813A1 (en) * 2018-09-17 2020-03-18 Institut d'Investigació Sanitària Pere Virgili Methods for the prognosis of hiv-infected subjects
JP7539399B2 (ja) * 2019-03-06 2024-08-23 ディアデム エス．アール．エル． アルツハイマー病の診断と予後判定におけるマーカーとしてのｐ５３ペプチド
WO2021097302A1 (en) * 2019-11-13 2021-05-20 University Of South Florida Systems and methods of deep learning for colorectal polyp screening
CN110951707B (zh) * 2019-12-31 2022-11-11 南京医科大学 丙酮酸激酶m2突变体及其在心血管疾病中的应用
CN115616230A (zh) * 2020-03-18 2023-01-17 龙海市第一医院 用于肝癌早期诊断的检测岩藻糖基化载脂蛋白h的elisa试剂盒
WO2022006628A1 (en) * 2020-07-08 2022-01-13 Southern Adelaide Local Health Network Inc. Computer-implemented method and system for identifying measurable features for use in a predictive model
CN112034182A (zh) * 2020-09-01 2020-12-04 复旦大学附属中山医院 一种结肠癌转移预测方法和系统
CN112194719A (zh) * 2020-09-01 2021-01-08 中日友好医院(中日友好临床医学研究所) Crt抗原和mage-a1抗原的制备及其应用
CN112266961B (zh) * 2020-10-29 2023-05-12 中山大学附属第六医院 Tsg-6基因在预测结直肠癌转移及预后方面的应用
CN112710856B (zh) * 2020-12-16 2022-12-02 江西省肿瘤医院(江西省癌症中心) 检测血清igf1蛋白的制剂在制备结直肠癌疗效监测试剂中的应用
CN113447658B (zh) * 2021-07-01 2022-04-19 浙江大学 一种检测抗过氧化物还原酶-1-IgG抗体的试剂盒
CN113956327B (zh) * 2021-10-11 2024-01-30 中山大学肿瘤防治中心 靶向人apc蛋白的多肽及其在制备药物中的应用
EP4497005A1 (en) * 2022-03-23 2025-01-29 Serum Detect, Inc. Biomarker signatures indicative of early stages of cancer
CN114445406B (zh) * 2022-04-07 2022-08-09 武汉大学 肠镜图像分析方法、装置和医学图像处理设备
TWI796228B (zh) 2022-05-25 2023-03-11 臺中榮民總醫院 急性腎損傷預測系統及其方法
CN114668836B (zh) * 2022-05-27 2022-08-19 暨南大学 Pdia6在制备治疗脊髓损伤和修复的药物中的应用
CN114958794B (zh) * 2022-06-14 2023-06-02 南京工业大学 一种苯乙醇胺-N-甲基转移酶hPNMT54及其克隆表达与应用
CN116593431B (zh) * 2023-04-09 2025-11-07 湖南科技大学三亚研究院 一种基于亲和传感器法的米酵菌酸毒素便携式检测装置及检测方法
US20240379228A1 (en) * 2023-05-08 2024-11-14 Venn Biosciences Corporation Diagnosis of colorectal cancer using targeted quantification of peptides
WO2025058445A1 (ko) * 2023-09-15 2025-03-20 연세대학교 산학협력단 대장암에 대한 정보 제공 방법
CN118067993B (zh) * 2024-04-17 2024-07-05 弗雷米德生物医药技术（天津）有限公司 一种用于肠息肉检测的联检试剂盒及其制备方法、检测方法和应用
CN118496322A (zh) * 2024-05-09 2024-08-16 昆明医科大学 一种靶向降解β-catenin的多肽型抑制剂及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4517289A (en) * 1982-08-18 1985-05-14 Brigham And Women's Hospital Monoclonal antibodies for human tissue cross-matching
EP0854934A4 (en) * 1995-08-18 2000-09-06 Donald W Landry DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS
US5800347A (en) * 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
NO954667D0 (no) * 1995-11-17 1995-11-17 Dagfinn Oegreid Fremgangsmåte til deteksjon av Ki-ras mutasjoner
JP2002543855A (ja) * 1999-01-10 2002-12-24 エグザクト サイエンシーズ コーポレイション Ｂａｔ−２６遺伝子座における変異を検出するアッセイを実施することによって結腸直腸疾患を検出する方法
US20010041365A1 (en) * 2000-01-10 2001-11-15 Michael Laposata Methods for monitoring alcohol consumption
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
US20050153382A1 (en) * 2002-06-06 2005-07-14 Chengdu Kuachang Science And Technology Co., Ltd. Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
EP2026071B1 (en) * 2004-02-19 2013-07-31 Yale University Identification of cancer protein biomarkers using proteomic techniques
DK1761779T3 (da) * 2004-08-13 2008-02-25 Indivumed Gmbh Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem
US20060105419A1 (en) * 2004-08-16 2006-05-18 Biosite, Inc. Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
WO2006094149A2 (en) * 2005-03-01 2006-09-08 Exact Sciences Corporation Methods and compositions for detecting adenoma
CN101283280A (zh) * 2005-08-18 2008-10-08 Zadec私人有限公司 用于诊断结直肠癌的蛋白质标记和所述标记作为所述癌症类型治疗的药物靶点的用途
WO2007141595A2 (en) * 2005-11-10 2007-12-13 Aurelium Biopharma Inc. Method of diagnosing breast cancer using protein markers
CN101802616B (zh) * 2007-07-19 2014-10-15 生物梅里埃公司 体外诊断结肠直肠癌的肝脂肪酸结合蛋白、cea和ca19-9测定方法
EP2195658A2 (en) * 2007-09-28 2010-06-16 Royal College of Surgeons in Ireland A method of assessing colorectal cancer status in an individual
ES2527649T3 (es) * 2007-12-10 2015-01-28 F. Hoffmann-La Roche Ag Panel de marcadores para el cáncer colorrectal
AU2008335855B2 (en) * 2007-12-10 2012-08-30 F. Hoffmann-La Roche Ag Seprase as a marker for cancer
EP2247754A1 (en) * 2008-02-11 2010-11-10 Hadasit Medical Research Services & Development Limited Colon cancer associated transcript 1 (ccat1) as a cancer marker
JPWO2009107170A1 (ja) * 2008-02-29 2011-06-30 学校法人日本大学 抗ｃｒｐ抗体及びその利用
WO2009115920A1 (en) * 2008-03-18 2009-09-24 Epigenomics Ag A method for optimizing and validating an assay for determining the presence or absence of a medical condition
CA2724433A1 (en) * 2008-05-14 2009-11-19 Eth Zuerich Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
US8697370B2 (en) * 2008-05-23 2014-04-15 Pronota N.V. Biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
CA2777800C (en) * 2009-10-15 2019-11-12 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
US10119959B2 (en) * 2010-06-25 2018-11-06 The Board Of Trustees Of The Leland Stanford Junior University Method of assaying an individual for immune impairment
US20140364326A1 (en) * 2011-01-28 2014-12-11 F. Hoffmann-La Roche Sa Combinatorial biomarkers for clinical applications in lung cancer patient management
WO2012115885A1 (en) * 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
EP2744919A4 (en) * 2011-08-19 2015-04-08 Myriad Genetics Inc GENE SIGNATURES FOR PROGNOSIS OF LUNG CANCER AND SELECTION OF THERAPY

Also Published As

Publication number Publication date
WO2014085826A3 (en) 2014-10-23
KR20150090240A (ko) 2015-08-05
CN110596385A (zh) 2019-12-20
AU2013351947A1 (en) 2015-06-18
US20150111223A1 (en) 2015-04-23
US20150111230A1 (en) 2015-04-23
BR112015012616A2 (pt) 2017-09-12
WO2014085826A2 (en) 2014-06-05
EP2926138A4 (en) 2016-09-14
CN104969071B (zh) 2019-09-03
EP2926138A2 (en) 2015-10-07
SG11201504241QA (en) 2015-06-29
CN104969071A (zh) 2015-10-07
US20150111221A1 (en) 2015-04-23
CA2893158A1 (en) 2014-06-05
JP2016507723A (ja) 2016-03-10
US20150111220A1 (en) 2015-04-23
US20170285033A1 (en) 2017-10-05
US20140234854A1 (en) 2014-08-21

Similar Documents

Publication Publication Date Title
MX2015006757A (es) Método para la evaluación de la presencia de o riesgo de tumores de colon.
Daughton Using biomarkers in sewage to monitor community-wide human health: Isoprostanes as conceptual prototype
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
MX2020001156A (es) Metodo para el pronostico y tratamiento de metastasis de cancer.
AR098155A1 (es) Métodos para diagnosticar y tratar trastornos eosinofílicos
MX361058B (es) Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero.
WO2014020502A3 (en) Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
HK1248316B (zh) 评估个体结肠直肠健康的方法
EA201590773A1 (ru) Способ диагностики для прогнозирования ответа на ингибитор фактора некроза опухоли альфа (tnf альфа)
BR112015023120A2 (pt) método para identificar um indivíduo com uma doença ou disfunção, método para prever a responsividade de um indivíduo com uma doença ou disfunção, método para determinar a probabilidade de que um indivíduo com uma doença ou disfunção exibirá benefício do tratamento, método para selecionar uma terapia, usos de um antagonista de ligação do eixo pd-l1, ensaio para identificar um indivíduo com uma doença, kit de diagnóstico, método para avaliar uma resposta ao tratamento e método para monitorar a resposta de um indivíduo tratado
MX2016012697A (es) Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.
MX368099B (es) Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib.
NI201300013A (es) Análisis de biomarcadores para detectar o medir la inhibición de la actividad de la cinasa tor
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
WO2015109263A3 (en) Biomarkers for detecting and monitoring colon cancer
WO2013028680A3 (en) Method and apparatus for detecting a biomarker in the presence of electrical stimulation
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
BRPI0509979A (pt) método para detectar ncrna
EA201390150A1 (ru) Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма
MX2015015532A (es) Metodo y sistema de identificacion de biomarcadores.
BR112013023050A2 (pt) “antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um composto candidato, para produzir in vitro células epiteliais primárias, para diagnosticar câncer de próstata, para selecionar um tratamento para um indivíduo tendo um câncer/tumor de próstata, linhagem de célula, e, modelo animal”
EP2598873A4 (en) BIOMARKERS FOR PROSTATE CANCER AND METHOD FOR THEIR USE
HK1197085A1 (en) Genetic variants for predicting risk of breast cancer
EA201490946A1 (ru) Способ количественной оценки лечения рака
BR112015019567A2 (pt) marcadores associados com inibidores de wnt